As the activation of HCAR1 in BAT induces antilipolytic and antidiabetic effects, our findings have potential to lead to the discovery of novel therapeutic targets for better treatment of type 2 diabetes. This evidence concerns the gene HCAR1 and type 2 diabetes mellitus.